Planet Labs PBC
NYSE:PLAerospace & Defense
+$0.01 today
- Market cap
- $4.10B
- Beta
- 2.00
- P/E (TTM)
- -26.1
- EPS (TTM)
- -$1.08
Volume 4.99M
Average 14.88M
PL Sales of Investments
Cash received from selling or redeeming investments.
Planet Labs PBCNYSE: PL
Sales of Investments · Q2 FY2027 · quarter ended Jul 2026
Sales of investments growth accelerates
Q2 FY2027 sales of investments of $87.49M rose 467.2% year over year, ahead of the +151.9% change in trailing-twelve-month sales of investments. Sequentially, it rose 133.4% from the prior quarter. Over 3 fiscal years it compounded at +17.7% a year.
Context
- Sales of investments amounted to 29.2% of revenue in FY2026, up 4.1 pp from a year earlier.
- Sales of investments increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +467.2% holds above the trailing-twelve-month pace of +151.9%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2026
- 90.01M USD
- Year-over-year change
- +46.6%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 90.01M | +46.6% |
| FY2025 | 2025-01-31 | 61.4M | -70.3% |
| FY2024 | 2024-01-31 | 206.9M | +275.0% |
| FY2023 | 2023-01-31 | 55.17M | — |
| FY2022 | 2022-01-31 | 0 | — |
Sales of Investments vs competitors
How PL compares with its peers on the latest reported figures
- PL's LTM Jul 2026 sales of investments of $211.68M is the 2nd largest of the 10 companies compared; the peer median is $1.81M.
- Its year-over-year change of +151.9% is the 2nd highest of 5, against a peer median of +43.8%.
- Sales of investments amounts to 56.0% of revenue for PL, versus a peer median of 0.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $874.39M | -40.7% | -9.5% | 20.9% | |
| LTM Jul 2026 | $211.68M | +151.9% | +17.7% | 56.0% | |
| LTM Jul 2026 | $157.5M | +36.0% | -7.6% | 13.3% | |
| LTM Sep 2026 | $108.41M | — | — | 29.5% | |
| LTM Jun 2026 | $43.01M | +51.5% | +60.8% | 0.7% | |
| LTM Jun 2026 | $1.81M | +201.2% | — | 0.1% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Oct 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding PL) | $1.81M | +43.8% | -7.6% | 0.1% | |
Competitors are the stored peer set for PL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | (137.12M) | (161.97M) | (140.51M) | (123.2M) | (246.86M) |
| Depreciation & Amortization | 45.04M | 43.33M | 47.64M | 45.64M | 41.83M |
| Deferred Income Tax | (1.39M) | (456K) | 0 | 0 | 0 |
| Stock-Based Compensation | 41.96M | 75.54M | 57.13M | 48.49M | 55M |
| Change in Working Capital | 9.54M | (23.88M) | 3.8M | (2.93M) | 121.31M |
| Accounts Receivables | 3.26M | 6.31M | (2.66M) | (11.98M) | (30.23M) |
| Inventory | 0 | 0 | 0 | 0 | (609K) |
| Accounts Payables | 16.07M | (2.99M) | (25.01M) | (13.34M) | 13.8M |
| Other Working Capital | (9.8M) | (27.21M) | 31.47M | 22.39M | 138.35M |
| Other Non-Cash Items | (232K) | (6.5M) | (18.77M) | 17.63M | 163.09M |
| Operating Cash Flow | (42.21M) | (73.93M) | (50.71M) | (14.37M) | 134.36M |
| Capital Expenditures | (14.93M) | (12.76M) | (42.41M) | (44.3M) | (76.71M) |
| Acquisitions (Net) | (9.62M) | (3.82M) | (7.54M) | (1.07M) | (5.4M) |
| Purchases of Investments | 0 | (280.3M) | (189.14M) | (140.24M) | (428.01M) |
| Sales of Investments | 0 | 55.17M | 206.9M | 61.4M | 90.01M |
| Other Investing Activities | (598K) | (557K) | (5.81M) | 182.12M | 27M |
| Investing Cash Flow | (25.15M) | (242.26M) | (33.59M) | 57.91M | (393.12M) |
| Debt Repayment | (66.95M) | 0 | 0 | 0 | 406.27M |
| Common Stock Issued | 0 | 0 | 0 | 5.92M | 35.36M |
| Common Stock Repurchased | (5.6M) | (6.34M) | (8.97M) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 561.73M | 14.2M | 7.37M | (21.46M) | (84.57M) |
| Financing Cash Flow | 489.18M | 7.86M | (1.6M) | (15.54M) | 357.05M |
| Effect of Forex Changes | (1.55M) | (402K) | 17K | (201K) | 7.26M |
| Net Change in Cash | 420.27M | (308.74M) | (85.88M) | 27.8M | 105.56M |
| Free Cash Flow | (57.14M) | (86.69M) | (93.12M) | (58.67M) | 57.65M |
Planet Labs PBC
NYSE:PL
Intrinsic Alpha fair value
Locked
Current Price
$12.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.